Selected article for: "benefit risk and risk profile"

Author: Penso, L.; Dray‐Spira, R.; Weill, A.; Zureik, M.; Sbidian, E.
Title: Drop in biological initiation for patients with psoriasis during the COVID‐19 pandemic
  • Cord-id: 69p2u23n
  • Document date: 2021_6_14
  • ID: 69p2u23n
    Snippet: Biologics have become the backbone of chronic inflammatory diseases treatment, including psoriasis. Post-approval studies allowed to better understand their safety profile demonstrating a favorable risk-benefit ratio despite an increased risk of infection, and especially an increased risk of bacterial infection with anti-TNF agents.
    Document: Biologics have become the backbone of chronic inflammatory diseases treatment, including psoriasis. Post-approval studies allowed to better understand their safety profile demonstrating a favorable risk-benefit ratio despite an increased risk of infection, and especially an increased risk of bacterial infection with anti-TNF agents.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1
    Co phrase search for related documents, hyperlinks ordered by date